TB Alliance Enters into Collaboration with Sanofi-Aventis K.K. to Fight Tuberculosis
PARIS--(BUSINESS WIRE)--The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis (TB). The TB Alliance is a not-for-profit, product development partnership, whose goal is the development of new TB drugs.